A major global health threat is the emergence of antibiotic-resistant microbes. Coupled with a lack of development of modified antibiotics, there is a need to develop new antimicrobial molecules and screening assays for them. In this study we provide proof of concept that a large unilamellar vesicle (LUV) method used to study chloride ion efflux facilitated by ionophores and surfactant-like molecules that disrupt membrane integrity can be adapted to identify membrane interactive antimicrobial peptides (AMPs) and to screen relative activity 
Abstract (250 words)
A major global health threat is the emergence of antibiotic-resistant microbes. Coupled with a lack of development of modified antibiotics, there is a need to develop new antimicrobial molecules and screening assays for them. In this study we provide proof of concept that a large unilamellar vesicle (LUV) method used to study chloride ion efflux facilitated by ionophores and surfactant-like molecules that disrupt membrane integrity can be adapted to identify membrane interactive antimicrobial peptides (AMPs) and to screen relative activity of AMPs. Lucigenin was encapsulated in LUVs in the presence of Cl -ion (NaCl) which quenches fluorescence and then incubated with AMPs in 100 mM NaNO 3 buffer. With AMP membrane interaction/disruption, the Cl -ion is exchanged with the NO 3 - for cancer-related deaths. [1] A World Health Organisation report on antibiotic resistance has also stressed the need for "fostering innovation and research and development of new tools"
to advance progress in antimicrobial discoveries. [2] Despite these reported concerns, the pharmaceutical pipeline for the development of new antibiotics has significantly diminished.
This has been largely attributed to the revenue return being low for antibiotics as a result of the rapid resistance development to traditional antibiotic mimics. [3] [4] Thus there is a clear need for the development of new, effective antimicrobials which do not induce resistance like the traditional antibiotics; however, to assist with this development there is a requirement for relevant, high throughput screening assays.
Over the past two decades, hundreds of peptides, readily water soluble, with potent antimicrobial activity have been isolated from single celled organisms, invertebrates and vertebrates. [5] These antimicrobial peptides (AMPs) are being heralded as a new class of therapeutics for several reasons. [6] Their mechanism of microbial killing is distinct from currently used antibiotics and they do not readily induce resistance. [7] Furthermore, modified natural AMPs can have enhanced microbial membrane targeting ability and can be effective at nanomolar (nM) concentrations. [8] Typically, AMPs are 7-50 amino acids long making them accessible to chemical synthesis and modification. This has led to a large number of studies systematically investigating the importance of the size, sequence, net charge, conformation, structure, hydrophobicity and amphipathicity on the activity of AMPs. [9] [10] These studies have shown that each of these peptide characteristics is important for AMP activity and that modifying these characteristics can have significant effects on AMP activity. [5] A prerequisite for the action of any AMP is its interaction with the cell membrane of a microbe. By studying these interactions and binding kinetics with membrane and cytosolic molecules the mode of action of AMPs has been described as targeting either the inner/cytoplasmic membrane or intracellular molecules such as a protein or DNA/RNA. [5] Thus a microbe is killed via either membrane barrier disruption (channel/pore formation resulting in membrane depolarization and/or lysis) or inhibiting specific metabolic pathways, gene regulation or inducing aggregation/inactivation of intracellular macromolecular structures. These different mechanisms of killing are thought to be AMP sequence dependent.
However, the stratification of AMPs based on their specific mechanism of activity may not be that straightforward as some AMPs have recently been shown to have multimodal mechanisms of action. AMPs once thought to only target intracellular molecules and processes can also interact with the inner/cytoplasmic membrane of bacteria disrupting integrity. [11] [12] [13] Methods currently used to identify peptides as having antimicrobial activity are based on bacterial growth assays to determine Minimum Inhibitory Concentration (MIC) and/or to the development of in silico systems [14] [15] and the use of dye release large unilamellar vesicles (LUV) assays. [16] [17] The in silico methods have had successes [14] but are limited to using natural amino acids to alter the AMP sequence and to model activity. [17, [19] [20] The LUV dye release assays have the advantage that they are highly accessible, rapid and can be used for screening, but are limited to AMPs that disrupt or form pores in the membrane. Further these assays are dependent on the Stoke's radius of the dye; the small dyes (calcein, ANTS and DPX) with a Stoke's radius of 0.4-0.6 nm are not able to detect the pore forming peptide alamethicin which can form a pore with an internal diameter of 0.25 nm. [13] In this proof-of-concept study we show that a LUV method used to study chloride ion efflux facilitated by ionophores and surfactant-like molecules that disrupt membrane integrity. [21] [22] can be adapted to identify membrane interactive AMPs and screen relative activity of AMPs (Scheme 1). [23] this assay has been used to monitor Cl -ion movement across membranes. We hypothesised that this lucigenin-based Cl -ion efflux assay could be a sensitive assay for identifying membrane interactive AMPs. The assay could also be used to compare the relative activity of different AMPs and be a pre-biological screening assay to help identify lead AMPs and analogues for biological testing.
The AMPs used in this study were synthesized by solid phase peptide chemistry using the Fmoc/tBu protocol on Rink AMSURE resin or Fmoc Rink amide polystyrene resin as previously described. [12] [13] The purified (>95%) AMPs and their observed and calculated masses are listed in Table 1 . As lucigenin fluorescence is affected by pH, [22] our initial studies using two well defined pore forming peptides, maculatin 1.1 and ovispirin, were completed over a pH range from 5.5 to 8.0. Lucigenin/NaCl/phosphate buffer LUVs (lucigenin-LUVs)
were incubated with maculatin 1. showing maximal lucigenin fluorescence at pH 7.0 is in contrast to Graefe et al. [22] who showed that lucigenin in solution or incorporated into polyacrylamide nanoparticles had greater fluorescence at pH values less than 7.0. This discrepancy may be explained as lucigenin fluorescence is reported to be stabilized and enhanced in water/organic solvent mixtures and particularly with aliphatic compounds. [24] Thus a liposome environment may mimic this water/organic solvent effect on lucigenin fluorescence. Based on these results all further lucigenin-LUV assays were conducted at pH 7.0.
As AMPs are able to induce chloride ion efflux and lucigenin fluorescence in the lucigenin-LUV assay, we wanted to then investigate whether relative activity of AMPs could be differentiated and if LUV lipid composition would have an effect on this relative activity. However, the MIC/MBC and IC50 values in Table 2 demonstrate that this is not the case.
This phenomenon where AMPs interact more with an overall neutral lipid (POPC) LUV than a negatively charged lipid (POPE:POPG) LUV has been reported previously by Sani et al. [25] using maculatin 1.1 and aurein 1.2 AMPs. In the Sani et al. study, [25] it was found that although the AMPs were more potent against neutral vesicles in the dye release assay, upon mixing the neutral lipid vesicles with anionic lipid vesicles the AMPs migrated to the anionic lipids indicating more stable binding to these molecules. This highlights the importance of closely replicating the lipid composition of the bacterial and host cell membranes in the liposomes produced for the assay. This is further supported as the lipid composition of LUVs is well known to alter the binding of AMPs and membrane interactive compounds. [18, 26] Here
we have used published model lipid compositions to represent "typical" Gram negative bacteria and mammalian cells as a proof of concept for the assay. This is a limitation in our Table 3 and shows the considerable variation in the concentration and type of lipid in the different species. To further the research from this study, formulating LUVs to represent the major cytoplasmic/inner membrane lipids of different bacterial species as described in Table   3 would enhance specificity and give greater insight into targeting particular species. Further, by using the co-mixing strategy described in the Sani et al. study [25] this would give insight into AMP specificity toward particular bacteria and/or mammalian cells. These are part of an ongoing investigations in our laboratory.
Recently we have shown that the proline-rich, cationic AMP Chex1-Arg20, which is thought to kill bacteria via a mechanism mediated by binding to the intracellular targets, heat shock protein DnaK also strongly interacts with the cytoplasmic/inner membrane. [12] Furthermore, Chex1-Arg20 interacts with negatively charged liposomes and sequentially induces their aggregation without calcein leakage. [27] It has been reported that for a few cationic AMPs, initial membrane interaction to form a surface lipid raft can result in a hyperpolarized membrane due to the additional positive charge of the AMP at the surface. However, with time and an increased concentration of the AMP it can insert into the membrane to span the membrane and form an ion channel. In the presence of high concentrations of extracellular Cl -, the anion can diffuse down a concentration gradient into the cell which increases the membrane potential even further thereby enhancing the membrane hyperpolarization. [28] [29] Using Chex1-Arg20 in the lucigenin-LUV assay, it can be clearly seen that for the POPE:POPG LUVs there was a strong chloride ion efflux and lucigenin fluorescence and that this was dose dependent ( Figure 3A) . However, unlike the pore-forming peptides above, Chex1-Arg20 did not induce lucigenin fluorescence in the POPC LUVs ( Figure 3A) . Using (Figure 3B and 3C) . The flow cytometry dot plots ( Figure 3B) show a significant shift in the red fluorescence of the E. coli population at both concentrations indicating a hyperpolarized membrane state. This is significantly different from incubating E. coli with carbonyl cyanide 3-chlorophenylhydrazone (CCCP) which collapses the proton motive force and so produces a depolarized membrane state (increased green fluorescence) which is similar to that induced by pore forming and gross membrane disrupting peptides (Figure 3B and 3C) . [12] The transmembrane Cl -ion movement seen in the lucigenin-(POPE:POPG) LUV assay with Chex1-Arg20 suggests that the hyperpolarization of E. coli by Chex1-Arg20 is the result of chloride ion influx as described above. Further it may suggest that Chex1-Arg20 has a multi-modal action of killing: an intracellular mechanism and another mechanism involving membrane hyperpolarization. The inability of Chex1-Arg20 to induce chloride ion efflux in the POPC LUVs is consistent with its very low/no cytotoxicity to mammalian cells ( Table 2 ) and its reported low overall toxicity. [12, 30] It is noteworthy that our assay result may provide, for the first time, a mechanism which explains that the lack of toxicity of Chex-Arg20 may be attributable to the peptide not interacting in a stable way with the mammalian membrane.
Conclusions
There is a need for the development of new antimicrobial molecules to combat the rise in antibiotic resistant bacteria. To assist in this development there is also a requirement for peptide and medicinal chemists to have a chemical based assay to pre-screen and identify lead AMPs prior to biological testing. Here we provide proof of concept that a chloride ion efflux The antimicrobial peptide (AMPs) ( Table 1) were chemically synthesized by solid phase peptide synthesis (SPPS) on a CEM Liberty microwave peptide synthesizer (Ai Scientific, Victoria) as previously described. [12] [13] Briefly, the peptide-resins were assembled reversed phase column (9.4 mm × 25 cm). Crude peptide analysis/purification was achieved using a linear acetonitrile gradient in 0.1% TFA at a flow rate of 2 mL/min (linear gradient of 10 to 50% CH 3 CN over 15 min, followed by a 50 to 100% CH 3 CN over 50 min). Analytical RP-HPLC of the purified peptide was achieved using a Zorbax 300 SB-C18 reversed phase column (4.6 mm × 15 cm) using a linear acetonitrile gradient in 0.1% TFA at a flow rate of 2 mL/min (linear gradient of 10 to 100% CH 3 CN over 30 min). Analysis of the purified peptide was performed using an Bruker Ultraflex III MALDI TOF/TOF. One microliter of HPLC eluted purified peptide was deposited on to a prespotted HCCA (α-cyano-4-hydroxycinnamic acid) Anchor Chip II (PAC II) and MS spectra acquisition performed manually was carried in reflectron mode measuring from 700 to 4000 Da, using an accelerating voltage of 25 kV. All MS spectra were produced from five sets of 100 laser shots and calibration of the instrument was performed externally with ions of pre-spotted internal standards. Each of the purified peptides gave the expected masses ( University of Melbourne, Victoria. This strain was selected for this study as it is widely used in AMP studies and is a Gram negative bacterium and growth conditions were as previously described. [13] Briefly, bacteria were grown aerobically and maintained by passage at ambient 
Antimicrobial Peptide Assays
Antibacterial assays were undertaken to determinate the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for each of the AMPs using assays previously described. [13] Briefly, E. coli stock solution (2.5 10 6 cells/mL) in the LB media was made and an aliquot incubated with AMPs within 15 minutes from viable cell count and stock preparation. All AMPs were dissolved in DMSO and a 500 µM stock solution prepared MIC, the CLSI broth microdilution assay [31] was followed and, for determination of MBC, the CLSI protocol [31] was also followed as we have previously described. [13] A minimum of 3 biological replicates were conducted for each AMP.
Mammalian Cell Cytotoxicity Assay
To determine the cytotoxicity of the AMPs, 100 µl of HEK-293 (ATCC CRL-1573TM) cells were provided by J. Rheinwald (Harvard Medical School, Cambridge, USA) [32] in keratinocyte serum-free medium supplemented with 0.2 ng/mL human EGF, 25 mg/mL bovine pituitary extract, 0.4 mM CaCl 2 , 100 U/mL penicillin, 100 mg/mL streptomycin, and 2 mM GlutaMAX-1 were seeded into 96-well plates containing 100 µL serial dilutions (250-0.244 µM) of the AMP in media and cultured at 37ºC, 5% CO 2 incubator. After 28 h, 20 µL
tetrazolium (MTS) solution (CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay kit, Promega) were added to each well and the plates were incubated for a further 1-2 h at 37ºC, 5% CO 2 incubator. Cell cytotoxicity was determined as previously described. [13] A minimum of 3 biological replicates were conducted for each AMP. Large unilamellar vesicles of POPC or POPE:POPG (7:3) to mimic mammalian or
Gram negative bacterium membranes, respectively were produced as we have previously described. [17] Briefly, phospholipids were co-solubilized in chloroform-methanol ( to remove un-encapsulated lucigenin with 100 mM NaNO 3 (20 mM phosphate buffer) for 6 hours.
Fluorescent Ion Efflux Assay
For fluorescent ion efflux assay AMPs were dissolved in 100 mM NaNO 3 (20 mM phosphate buffer) and 250-µL reaction samples were made of 250 µM LUV and appropriate amount of peptide to obtain an initial Lipid/Peptide (L/P) molar ratio of 50:1, where the initial peptide a known phospholipid compositions of bacteria compiled from [26, [33] [34] [35] and references therein. b PE = phosphatidylethanolamine, PG = phosphatidylglycerol, CL = cardiolipin, PC = phosphatidylcholine, Chol = cholesterol, PS = phosphatidylserine, PI = phosphatidylinositol, NL = neutral lipids, SM = sphingomyelin, Others = mainly glycolipids. c the total membrane percent of PE is given in no brackets and the total membrane percent of lysoPE (lysophosphatidylethanolamine) is given in brackets. d the total membrane percent of PG is given in no brackets and the total membrane percent of lysyl-PG (lysyl-phosphatidylglycerol) is given in brackets. d Mycobacterium tuberculosis is considered as Gram neutral as it has Gram positive and negative staining. 
